Ipas – Trademark Portfolio

Entity Type: 03

Ipas holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include IPAS and HEALTH. ACCESS. RIGHTS.. The owner is based in Durham, NC.

4711 Hope Valley Rd Ste 4F-720

Durham, NC 27707

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ipas's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (5 filings)

Education; providing of training; entertainment; sporting and cultural activities

16
Paper Goods (5 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ipas have?

Ipas has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 2 cancelled.

What trademark classes does Ipas file in?

Ipas files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 10 (Medical Apparatus). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Ipas's most well-known trademarks?

Ipas's registered trademark portfolio includes well-known marks such as IPAS and HEALTH. ACCESS. RIGHTS.. These are among 3 currently registered trademarks in the portfolio.

What is Ipas's trademark registration success rate?

Ipas has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.